Comparative Analysis of the Endogenous Peptidomes Displayed by HLA-B*27 and Mamu-B*08: Two MHC Class I Alleles

Miguel Marcilla1, Iñaki Alvarez2, Antonio Ramos-Fernández3

  • 1Proteomics Unit, Spanish National Biotechnology Centre (CSIC), Darwin 3, 28049 Madrid, Spain.

Insights

Indian rhesus macaques and humans share similarities in controlling viral replication through specific MHC class I alleles. Researchers found Mamu-B*08 and HLA-B*27 share peptide binding motifs, aiding SIV epitope discovery.

Area of Science:

  • Immunology
  • Virology
  • Genetics

Background:

  • Indian rhesus macaques are crucial animal models for AIDS research.
  • MHC class I alleles like Mamu-B*08 in macaques and HLA-B*27/HLA-B*57 in humans are associated with control of SIV/HIV infection.
  • Previous studies suggest sequence similarity in peptides displayed by Mamu-B*08 and HLA-B*27.

Purpose of the Study:

  • To precisely map the peptide-binding motif of Mamu-B*08.
  • To compare the Mamu-B*08 binding motif with that of HLA-B*27.
  • To understand the molecular basis of peptide presentation by Mamu-B*08 for SIV epitope identification.

Main Methods:

  • Affinity purification of peptidomes bound to Mamu-B*08 and HLA-B*27.
  • Liquid chromatography-mass spectrometry (LC-MS) analysis of endogenous ligands.
  • Sequence analysis of identified peptides to determine binding motifs.
  • In silico binding efficiency estimation and competitive binding assays.

Main Results:

  • Thousands of endogenous ligands were identified for Mamu-B*08 and HLA-B*27.
  • Both allotypes showed a preference for arginine at peptide position 2 (P2).
  • Mamu-B*08 displayed shorter, lower molecular weight peptides, preferred glutamine at P2, and had a more restrictive C-terminal anchor (PΩ) preference (leucine, phenylalanine) compared to HLA-B*27.
  • In silico and binding assays confirmed the correlation between the characterized motif and binding affinity.

Conclusions:

  • The study fine-mapped the Mamu-B*08 binding motif, revealing similarities and key differences with HLA-B*27.
  • Understanding these motifs enhances knowledge of peptide presentation by Mamu-B*08.
  • This research can facilitate the discovery of novel SIV epitopes restricted by the Mamu-B*08 allotype.

Related Concept Videos